Close



Apr 2, 2024 08:16AM
Jan 11, 2024 07:02AM
Jan 11, 2024 07:00AM
Jan 3, 2024 07:15AM
Oct 24, 2023 07:00AM
Sep 26, 2023 08:00AM
Aug 9, 2023 04:01PM Harrow Announces Second Quarter 2023 Financial Results
Jul 31, 2023 07:00AM
Jul 31, 2023 07:00AM
Jul 19, 2023 07:00AM
Jul 19, 2023 07:00AM
Jul 18, 2023 05:00PM
Jul 18, 2023 05:00PM
Jul 18, 2023 04:05PM Harrow Provides Select Preliminary Second Quarter 2023 Financial Guidance
Jul 18, 2023 04:04PM
Jul 18, 2023 04:04PM
Jul 18, 2023 04:01PM
Jul 18, 2023 04:01PM
May 17, 2023 08:00AM
May 11, 2023 04:01PM
May 4, 2023 08:01AM Harrow Health (HROW) to Launch FDA-Approved IHEEZO at the 2023 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
May 4, 2023 08:00AM
May 2, 2023 07:00AM
Apr 27, 2023 08:00AM
Mar 28, 2023 02:59PM
Mar 28, 2023 07:07AM
Mar 28, 2023 07:00AM
Mar 23, 2023 04:06PM Harrow Announces Fourth Quarter and Year-End 2022 Financial Results
Mar 13, 2023 07:00AM
Mar 13, 2023 07:00AM
Mar 6, 2023 08:00AM
Mar 2, 2023 08:00AM
Feb 15, 2023 07:00AM
Feb 2, 2023 06:33AM
Feb 2, 2023 06:30AM Harrow Announces Permanent, Product-Specific J-Code (J2403) for IHEEZO™ (Chloroprocaine Hydrochloride Ophthalmic Gel) 3% for Ocular Surface Anesthesia Effective April 1, 2023
Jan 23, 2023 07:00AM
Jan 5, 2023 07:00AM
Dec 21, 2022 09:22AM
Dec 21, 2022 09:21AM
Dec 14, 2022 06:33AM
Dec 14, 2022 06:30AM
Nov 30, 2022 08:00AM Harrow and iOR Partners Expand National Product Supply Agreement
Nov 14, 2022 04:05PM
Nov 10, 2022 08:01AM
Nov 10, 2022 08:00AM
Oct 27, 2022 08:00AM
Oct 5, 2022 05:35PM
Sep 29, 2022 07:05AM
Sep 29, 2022 07:00AM ImprimisRx Launches Fortisite™ (Tobramycin 1.5% + Vancomycin 5%) Compounded Antibiotic Formulation
Sep 28, 2022 05:53AM

251,531 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All